Prevalence of cardiovascular drug-related adverse drug reactions consultations in UK primary care: A cross-sectional study
- PMID: 39046945
- PMCID: PMC11268649
- DOI: 10.1371/journal.pone.0307237
Prevalence of cardiovascular drug-related adverse drug reactions consultations in UK primary care: A cross-sectional study
Abstract
Background: Adverse drug reactions (ADRs) represent a significant barrier to achieve optimal treatment outcomes. Cardiovascular drugs, including antihypertensive drugs, lipid-lowering drugs, and antithrombotic drugs, are among the most prescribed medications in the primary care setting.
Objectives: To estimate the prevalence of cardiovascular drug-related ADRs consultations in United Kingdom (UK) primary care and identify risk factors of these ADRs.
Methods: This was a cross-sectional study of cardiovascular drug users between 2000-2019 using UK IQVIA Medical Research Data. ADRs consultations were identified using database screening method employing standardised designated codes. The overall and annual age-standardised prevalence was estimated using direct standardisation method using 2019 mid-year UK population. Risk factors of ADRs consultations were estimated using logistic regression model stratified by therapeutic areas.
Results: The standardised prevalence of consultations related to cardiovascular drugs ADRs was 10.60 (95% CI. 10.46, 10.75) per 1000 patients. Patients aged 70-79 years had the highest occurrence of ADRs consultations. The most frequently drug classes implicated in the ADRs consultations were statins (n = 9,993 events, 27.09%), beta-blockers (n = 8,538 events, 23.15%), ACEIs/ARBs (n = 8,345 events, 22.62%), and aspirin (n = 6,482 events, 17.57%). Risk factors of ADRs consultations were previous history of cardiovascular diseases, e.g., myocardial infarction and stroke; advanced age, comorbidities; diabetes and dyslipidaemia; and polypharmacy.
Conclusions: The burden of cardiovascular drug-related ADRs consultations in primary care was considerable. Statins, beta-blockers, ACEIs/ARBs, and aspirin were the most frequently implicated drug classes. Closer clinical monitoring should be performed for patients affected by the ADRs to mitigate the risk of suboptimal treatment outcomes.
Copyright: © 2024 Insani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Impact of ACEIs and ARBs-related adverse drug reaction on patients' clinical outcomes: a cohort study in UK primary care.Br J Gen Pract. 2023 Oct 26;73(736):e832-e842. doi: 10.3399/BJGP.2023.0153. Print 2023 Nov. Br J Gen Pract. 2023. PMID: 37783509 Free PMC article.
-
Statin-related adverse drug reactions in UK primary care consultations: A retrospective cohort study to evaluate the risk of cardiovascular events and all-cause mortality.Br J Clin Pharmacol. 2022 Nov;88(11):4902-4914. doi: 10.1111/bcp.15438. Epub 2022 Jun 23. Br J Clin Pharmacol. 2022. PMID: 35695656 Free PMC article.
-
Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit.Drugs Aging. 2014 Oct;31(10):769-76. doi: 10.1007/s40266-014-0206-0. Drugs Aging. 2014. PMID: 25200414
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis.PLoS One. 2021 May 26;16(5):e0252161. doi: 10.1371/journal.pone.0252161. eCollection 2021. PLoS One. 2021. PMID: 34038474 Free PMC article.
References
-
- NHS. National Prescription Cost Analysis England 2022/2023. https://www.nhsbsa.nhs.uk/statistical-collections/prescription-cost-anal... 2023.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical